Organization | University of Cambridge

University of Cambridge Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Cambridge United Kingdom (1209)

Organization Overview

First Clinical Trial

1991

Unregistered Trial 187083

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Alternative names

Addenbrookes | Addenbrookes Charitable Trust | Addenbrookes Hospital | Addenbrooke`s Hospital and University of Cambridge | Addenbrooke's Hospital, Cambridge | Addenbrooke's Hospital, Cambridge, UK | Addenbrookes Hospital, Cambridge, United Kingdom | Addenbrooke's Hospital, UK | Addenbrooke's Hospital University of Cambridge, UK | Addenbrookes Hosptal NHS Trust/ University of Cambridge | Addenbrookes NHS Trust | Addenbrooke's NHS Trust, Cambridge, United Kingdom | Adel Helmy | Arun Gupta | Bourn Hall Clinic, Bourn Hall, High Street, Bourn, Cambridge CB3 7TR | Breast Cancer Research Unit, University of Cambridge | Cambridge Biomedical Campus | Cambridge Centre for Brain Repair, Cambridge, UK | Cambridge Clinical Trials Unit | Cambridge Institute for Medical Research, Addenbrooke's Hospital | Cambridgeshire and Peterborough NHS Foundation Trust | Cambridge University | Cambridge University and Cambridge University Hospitals NHS Foundation Trust | Cambridge University Hospital | Cambridge University Hospital, Department of Neurosurgery | Cambridge University Hospitals | Cambridge University Hospitals NHS Foundation Trust | Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital | Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge | Cambridge University Hospitals NHS Foundation Trust (CAM) | Cambridge University Hospitals NHS Foundation Trust (joint Sponsor) | Cambridge University Hospitals NHS Foundation Trust & University of Cambridge | Cambridge University Hospitals NHS Foundation Trust/University of Cambridge | Cambridge University Hospitals, NHS Foundation Trust, University of Cambridge | Cambridge University Hospitals NHS Trust | Cambridge University, UK | Cambridge Unversity Hospitals NHS Foundation Trust; Unversity of Cambridge | CCTU | CCTU- Cancer Theme | CCTU-Core | Clinical Unit at Cambridge (Addenbrooks) | CRUK Cambridge Institute | CRUK Cambridge Institute and the University of Cambridge | CRUK Cambridge Institute, University of Cambridge | Department of Biological Anthropology, University of Cambridge | Department of Pathology University of Cambridge | Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Addenbrooke's Hospital, Hills Road, CB2 0QQ Cambridge, UK | Institute of Metabolic Science, Hills Road, CB2 0QQ, Cambridge, UK | Lisa Bax | Lupus and Vasculitis Service, Addenbrooke's Hospital | MRC Cancer Unit.University of Cambridge. | MRC Mitochondrial Biology Unit | Rachel Jones | Simon C Pacey, MD | The University of Cambridge, Department of Oncology | The University of Cambridge (joint Sponsor) | University Department of Radiology, University of Cambridge, Addenbrooke's Hospital, Hills Road, CB2 0QQ Cambridge, UK | University of Cambridge | University of Cambridge, Addenbrooke's Hospital, UK | University of Cambridge; honorary contract with Cambridge University Hospitals NHS Foundation Trust | University of Cambridge, UK | Wellcome Trust-MRC Institute of Metabolic Science University of Cambridge

University of Cambridge Report issue

Drugs in Phase 4 Trials (36)

Drugs in Phase 3 Trials (70)

Drugs in Phase 2 Trials (77)

Drugs in Phase 1 Trials (19)

Drugs in Other Trials (42)

Experimental Indications (Clinical Trials, Phases 1-4)

Overview